Remove 2025 Remove Pharmaceutical manufacturing Remove Physicians
article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

billion in 2025. Levrx also engages physician groups and members directly, giving healthcare consumers the information needed at the point of care to keep costs low, avoid prescription rewrites, and prevent cost-related non-adherence. andrew.mills@caretrack.com CareTrack Health is a fully integrated physician practice extension.

article thumbnail

CMS enters drug price negotiation arena in sea change for industry

Clarivate

In 2025, CMS will select another 15 Part D drugs for negotiations that will take effect in 2027. Although the initial set of drugs included for negotiations was limited to ten, the scope of this program will expand over time.